K. Kishi

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
K Kishi, K. Kishi, Kazuma Kishi
Publication record
253 papers · 6,128 citations · H-index 30

PAPERS

Deep-learning-based 3D content-based image retrieval system on chest HRCT: Performance assessment for interstitial lung diseases and usual interstitial pneumonia
20251 citationsauthor #16
Upregulation of long non‑coding RNA LINC00460 in EGFR‑mutant lung cancer indicates a poor prognosis in patients treated with osimertinib
20235 citationsauthor #6
ATS/JRS/ALAT Hypersensitivity Pneumonitis Guidelines for Diagnosis of humidifier lung and summer-type hypersensitivity pneumonitis.
20232 citationsauthor #15
Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non‐small‐cell lung cancer in KEYNOTE‐407
202312 citationsauthor #22
Prospective exosome-focused translational research for afatinib (EXTRA) study of patients with nonsmall cell lung cancer harboring EGFR mutation: an observational clinical study
20236 citationsauthor #22
Carboplatin and weekly paclitaxel in combination with bevacizumab for the treatment of advanced non-small cell lung cancer complicated by idiopathic interstitial pneumonias: A feasibility study.
20236 citationsauthor #14
Efficacy of three sputum specimens for the diagnosis of Mycobacterium avium complex pulmonary disease
202310 citationsauthor #8
Benefits of Pulmonary Rehabilitation in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Drug Treatment
202211 citationsauthor #8
P68-3 Phase 2 study comparing the efficacy between afatinib & osimertinib based on immunological biomarker in EGFR-mutant NSCLC
20220 citationsauthor #5
Chemotherapy versus best supportive care in advanced lung cancer and idiopathic interstitial pneumonias: A retrospective multi-centre cohort study.
20224 citationsauthor #12
Impact of chronic co-infection in pulmonary Mycobacterium avium complex disease after treatment initiation
20224 citationsauthor #11
Relationship Between 18F-fluorodeoxyglucose Uptake on Positron Emission Tomography and Aortic Calcification.
20221 citationsauthor #9
Obstructive pneumonia caused by Gordonia bronchialis with a bronchial foreign body.
20225 citationsauthor #11
A 52-Year-Old Obese Man With Persistent Cough.
20220 citationsauthor #9
Co‐infection with Nocardia spp. in a patient with Mycobacterium avium complex pulmonary disease: A case report
20224 citationsauthor #6
Determinants of Six-Minute Walk Distance in Idiopathic Pulmonary Fibrosis and Idiopathic Pleuroparenchymal Fibroelastosis
20223 citationsauthor #7
Impact of accurate diagnosis of interstitial lung diseases on postoperative outcomes in lung cancer
20224 citationsauthor #9
Utility of contrast-enhanced magnetic resonance lymphangiography for yellow nail syndrome with lymphangiopathy: a case report
20222 citationsauthor #6
Final report on plasma ctDNA T790M monitoring during EGFR-TKI treatment in patients with EGFR mutant non-small cell lung cancer (JP-CLEAR trial)
20222 citationsauthor #5
Genetic Analyses of Cell-Free DNA in Pancreatic Juice or Bile for Diagnosing Pancreatic Duct and Biliary Tract Strictures
20227 citationsauthor #8
Population-based incidence of hospitalized Clostridioides difficile infection among older adults in Ota-ku, Japan: A prospective surveillance study.
20224 citationsauthor #32
Efficacy and safety of first-line osimertinib treatment and postprogression patterns of care in patients with epidermal growth factor receptor activating mutation-positive advanced non-small cell lung cancer (Reiwa study): study protocol of a multicentre, real-world observational study
20227 citationsauthor #6
Serum autotaxin levels in chronic disease and acute exacerbation of fibrosing interstitial lung disease
20227 citationsauthor #8
Preoperative undernutrition predicts postoperative complications of acute empyema
20213 citationsauthor #7
P5‐40: An autopsy case of COVID‐19 with disseminated mucormycosis
20212 citationsauthor #11
P5‐73: Clinical characteristics of pulmonary melioidosis diagnosed at respiratory Department of the Tertiary Hospital in Southern Vietnam
20210 citationsauthor #14
Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum]
20210 citationsauthor #8
Elective lung resection after treatment for COVID-19 pneumonia
20215 citationsauthor #6
Association of rs3750920 polymorphism in TOLLIP with clinical characteristics of fibrosing interstitial lung diseases in Japanese
202112 citationsauthor #9
Rapid recovery achieved by intensive therapy after preterm cesarean section for worsening COVID-19-induced acute respiratory failure: A case report and literature review
20211 citationsauthor #6
Multifocal locules including the anterior mediastinum side as a surgical indicator in pleural infection
20210 citationsauthor #10
Clinical, Radiological and Pathological Characteristics of Ultrasonic Humidifier Lung and Summer-Type Hypersensitivity Pneumonitis
20210 citationsauthor #13
Immunohistochemical Detection of Propionibacterium acnes in Granulomas for Differentiating Sarcoidosis from Other Granulomatous Diseases Utilizing an Automated System with a Commercially Available PAB Antibody
202113 citationsauthor #14
Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan
20218 citationsauthor #8
Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
202121 citationsauthor #7
Bronchial Brushing and Diagnosis of Pulmonary Nontuberculous Mycobacteria Infection
20219 citationsauthor #10
A Resected Case of Combined Small Cell Carcinoma Containing Components of Squamous Cell Carcinoma, and Adenocarcinoma
20210 citationsauthor #7
P5‐72: Lipid involvements on inflammatory changes and clinical outcomes in patients with COVID‐19
20210 citationsauthor #14
Quantification of BIM mRNA in circulating tumor cells of osimertinib-treated patients with EGFR mutation-positive lung cancer.
20217 citationsauthor #14
Spigot in pneumothorax cavity: A rare complication of endobronchial Watanabe spigot
20210 citationsauthor #4
Appendicular Skeletal Muscle Mass Correlates with Patient-Reported Outcomes and Physical Performance in Patients with Idiopathic Pulmonary Fibrosis.
202118 citationsauthor #8
Exophiala dermatitidis pneumonia with bronchiectasis required prolonged voriconazole treatment
202113 citationsauthor #6
Sarcopenia in Idiopathic Pulmonary Fibrosis
20210 citationsauthor #8
P2‐38: Examination of microRNAs in serum exosomes in interstitial pneumonia
20210 citationsauthor #15
Have you ever seen the surface of a fractured metallic stent using a scanning electron microscope?
20210 citationsauthor #1
First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset
202111 citationsauthor #16
P34.07 Quantification of BIM mRNA In Circulating Tumor Cells Of Osimertinib-treated Patients with EGFR Mutation-positive Lung Cancer
20210 citationsauthor #8
Novel Artificial Intelligence-based Technology for Chest Computed Tomography Analysis of Idiopathic Pulmonary Fibrosis.
202153 citationsauthor #14
Severe spruelike enteropathy and collagenous colitis caused by olmesartan
202113 citationsauthor #5
Activation of G protein-coupled estrogen receptor ( GPER ) regulates ILC 2
20210 citationsauthor #15
Retraction
20210 citationsauthor #16
P5‐24: Severity and clinical outcome of SARS‐CoV‐2 infected patients following COVID vaccination – An observational study in Bangladesh
20210 citationsauthor #17
Incidence of acute exacerbation of idiopathic pulmonary fibrosis in patients receiving antifibrotic agents: Real-world experience.
202115 citationsauthor #8
Association of Diabetes Status With Survival After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: a Retrospective Study in Japan
20200 citationsauthor #8
First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset
202023 citationsauthor #16
Extracellular Vesicles from Fibroblasts Induce Epithelial Cell Senescence in Pulmonary Fibrosis.
202089 citationsauthor #12
Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan
202028 citationsauthor #4
Prognostic Factors in Myositis-Related Interstitial Lung Disease: A Retrospective Multicenter Study
20200 citationsauthor #14
Characteristics of non-small-cell lung cancer with interstitial pneumonia: variation in cancer location, histopathology, and frequency of postoperative acute exacerbations in interstitial pneumonia
20205 citationsauthor #7
Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia
202020 citationsauthor #10
Safety of bronchoscopy in patients with hematologic disorders
20200 citationsauthor #20
Randomized phase II trial of S‐1 plus cisplatin or docetaxel plus cisplatin with concurrent thoracic radiotherapy for inoperable stage III non‐small cell lung cancer
202014 citationsauthor #6
Thrombomodulin alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Randomized, Double-blind, Placebo-controlled Trial.
202063 citationsauthor #12
Efficacy of Anti-Fibrotic Treatments and Prognosis in Progressive Fibrosing Interstitial Lung Diseases Other Than Idiopathic Pulmonary Fibrosis
20200 citationsauthor #7
An elderly woman with severe enteritis mimicking infectious enteritis
20200 citationsauthor #4
Hypothesis generative head-to-head study comparing efficacy of afatinib and osimertinib based on immunological biomarkers in Japanese NSCLC patients with EGFR mutations (Heat on Beat study)
20209 citationsauthor #6
Plasma matrix metalloproteinase 7, CC-chemokine ligand 18, and periostin as markers for pulmonary sarcoidosis.
20207 citationsauthor #10
Difference in Radiological and Pathological Findings Depend on Its ANCA Subtypes in ANCA Positive Idiopathic Interstitial Pneumonias
20200 citationsauthor #5
A prospective study of selective pleural blood patching for pneumothorax due to computed tomography-guided percutaneous lung biopsy
20200 citationsauthor #10
Rare case of pulmonary sarcoidosis with cystic bronchiectasis
20202 citationsauthor #4
Clinical and radiological characteristics of ultrasonic humidifier lung and summer-type hypersensitivity pneumonitis.
202015 citationsauthor #13
Safety of bronchoscopy in patients with malignant hematologic disorders
20205 citationsauthor #20
Evaluation of a novel urinary antigen test kit for diagnosing Legionella pneumonia.
202029 citationsauthor #8
A phase I and extension study of S-1 and carboplatin for previously untreated patients aged 75 years or more with advanced non-small cell lung cancer -TCOG 1101-
20201 citationsauthor #3
Squamous cell transformation as a mechanism of acquired resistance to tyrosine kinase inhibitor in EGFR‐mutated lung adenocarcinoma: a report of two cases
202014 citationsauthor #5
Pirfenidone plus inhaled N-acetylcysteine for idiopathic pulmonary fibrosis: a randomised trial
202044 citationsauthor #17
Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia.
201939 citationsauthor #4
Development of a CT image case database and content-based image retrieval system for non-cancerous respiratory diseases: Method and preliminary assessment.
20197 citationsauthor #10
Selection of oral antifungals for initial maintenance therapy in chronic pulmonary aspergillosis: A longitudinal analysis.
201926 citationsauthor #10
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.
20192,620 citationsauthor #122
Eosinophilia during treatment of immune checkpoint inhibitors (ICIs) to predict succeeding onset of immune-related adverse events (irAEs).
201911 citationsauthor #15
Pneumatosis intestinalis induced by osimertinib in a patient with lung adenocarcinoma harbouring epidermal growth factor receptor gene mutation with simultaneously detected exon 19 deletion and T790 M point mutation: a case report
20197 citationsauthor #12
Analysis of systemic lupus erythematosus-related interstitial pneumonia: a retrospective multicentre study
201940 citationsauthor #13
Reduced area of the normal lung on high-resolution computed tomography predicts poor survival in patients with lung cancer and combined pulmonary fibrosis and emphysema.
20198 citationsauthor #13
A phase I and extension study of S-1 and carboplatin for previously untreated patients aged 75 years or more with advanced non-small cell lung cancer
20190 citationsauthor #4
Plasma ctDNA monitoring during epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor treatment in patients with EGFR-mutant non-small cell lung cancer (JP-CLEAR trial)
201918 citationsauthor #5
Analysis of Clinical Features by Both Diagnosis and Types of Antibodies in Patients with Myositis Related Interstitial Lung Disease: A Retrospective Multicenter Study
20190 citationsauthor #14
First-line onartuzumab plus erlotinib treatment for patients with MET-positive and EGFR mutation-positive non-small-cell lung cancer.
201914 citationsauthor #1
Ramsay-Hunt syndrome and subsequent sensory neuropathy as potential immune-related adverse events of nivolumab: a case report
201910 citationsauthor #8
Clinicoradiological Features of Pulmonary Tuberculosis with Interstitial Pneumonia
20195 citationsauthor #10
Treatment outcome of patients with unresectable stage III non-small cell lung cancer and interstitial pneumonia.
20192 citationsauthor #10
Clinical importance of long non-coding RNA LINC00460 expression in EGFR-mutant lung adenocarcinoma
201926 citationsauthor #12
Transformation of epidermal growth factor receptor T790M mutation‐positive adenosquamous carcinoma of the lung to small cell carcinoma and large‐cell neuroendocrine carcinoma following osimertinib therapy: an autopsy case report
201910 citationsauthor #6
What factors determine the survival of patients with an acute exacerbation of interstitial lung disease after lung cancer resection?
201810 citationsauthor #6
OK-432 pleurodesis for the treatment of pneumothorax in patients with interstitial pneumonia.
201823 citationsauthor #10
Prospective exosome‐focused translational research for afatinib study of non‐small cell lung cancer patients expressing EGFR (EXTRA study)
201813 citationsauthor #11
Chemoradiotherapy in Elderly Patients With Non–Small‐Cell Lung Cancer: Long‐Term Follow‐Up of a Randomized Trial (JCOG0301)
201830 citationsauthor #14
Clinical spectrum and prognostic factors of possible UIP pattern on high-resolution CT in patients who underwent surgical lung biopsy
201813 citationsauthor #12
Efficacy of combined therapy with pirfenidone and inhaled N-acetylcysteine for idiopathic pulmonary fibrosis: a randomized controlled phase 3 trial
20181 citationsauthor #16
Japanese guideline for the treatment of idiopathic pulmonary fibrosis.
201897 citationsauthor #12

TIMELINE

1984 0 citations

1986 0 citations

1992 0 citations

1998 44 citations

1999 78 citations

2000 4 citations

2001 42 citations

2002 144 citations

2003 25 citations

2004 112 citations

2005 206 citations

2006 191 citations

2007 66 citations

2008 39 citations

2009 19 citations

2010 79 citations

2011 51 citations

2012 30 citations

2013 272 citations

2014 293 citations

2015 282 citations

2016 101 citations

2017 213 citations

2018 323 citations

2019 2,843 citations

2020 368 citations

2021 204 citations

2022 65 citations

2023 41 citations

2025 1 citations

K. Kishi

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT